Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New approach aims to cut medication errors when seniors leave the hospital

NCT ID NCT06610214

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a program to help older adults (65+) better understand their medications when leaving the hospital. The program included an information package, better discharge paperwork, improved communication with doctors, and a follow-up call. The goal was to make patients feel more involved and reduce medication mistakes after they go home.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

231 people

The number who actually took part.

Started

Sep 2024

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 65 or older * Manages medication independently or with assistance from a caregiver Exclusion Criteria: * In the late palliative phase of care before or during the hospital stay * Transfer to a non-participating ward * Residence outside the hospital's county * Admission from or discharge to a nursing home or short-term care facility * Inability to independently receive information and give consent independently (e.g., cognitive impairment, non-contactable) * Death during hospital stay * Inability to communicate in Swedish * Previous inclusion in the study * Relocation where another department maintains care responsibility * No persistent medication change post-discharge * Hospital stay on the study ward of fewer than 48 weekday hours (excluding holidays)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Continuity of patient care are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Uppsala University Hospital

    Uppsala, Uppland, 75185, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.